In contrast, pharmacologic BAK activators are more limited, with only a single study describing BKA-073, a small molecule identified through computational screening and subsequently found to directly activate BAK to induce lung cancer cell apoptosis [27]. Here, BAK1 is linked to lung carcinoma.